(Q40754288)

English

Double-blind randomised trial of the antiemetic efficacy and safety of ondansetron and metoclopramide in advanced breast cancer patients treated with epirubicin and cyclophosphamide

scientific article published on January 1, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Double-blind randomised trial of the antiemetic efficacy and safety of ondansetron and metoclopramide in advanced breast cancer patients treated with epirubicin and cyclophosphamide (English)

1 reference

10.1016/0277-5379(91)90311-Z

https://api.crossref.org/works/10.1016/0277-5379(91)90311-Z

6 December 2022

1 reference

based on heuristic

inferred from title

1 reference

10.1016/0277-5379(91)90311-Z

https://api.crossref.org/works/10.1016/0277-5379(91)90311-Z

6 December 2022

author name string

N. W. Marschner

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835624

6 December 2022

M. Adler

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835624

6 December 2022

G. A. Nagel

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835624

6 December 2022

D. Christmann

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835624

6 December 2022

E. Fenzl

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835624

6 December 2022

B. Upadhyaya

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835624

6 December 2022

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 1991

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:027753799190311Z?httpAccept=text/xml

1 reference

10.1016/0277-5379(91)90311-Z

https://api.crossref.org/works/10.1016/0277-5379(91)90311-Z

6 December 2022

https://api.elsevier.com/content/article/PII:027753799190311Z?httpAccept=text/plain

1 reference

10.1016/0277-5379(91)90311-Z

https://api.crossref.org/works/10.1016/0277-5379(91)90311-Z

6 December 2022

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

1137-1140

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Combination Chemotherapy for Advanced Breast Cancer: Response and Effect on Survival

1

1 reference

10.1016/0277-5379(91)90311-Z

https://api.crossref.org/works/10.1016/0277-5379(91)90311-Z

6 December 2022

Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: a prospective randomized study

2

1 reference

10.1016/0277-5379(91)90311-Z

https://api.crossref.org/works/10.1016/0277-5379(91)90311-Z

6 December 2022

[French FAC vs FEC study in advanced breast cancer]

3

1 reference

10.1016/0277-5379(91)90311-Z

https://api.crossref.org/works/10.1016/0277-5379(91)90311-Z

6 December 2022

The course of nausea and vomiting after high-dose cyclophosphamide

8

1 reference

10.1016/0277-5379(91)90311-Z

https://api.crossref.org/works/10.1016/0277-5379(91)90311-Z

6 December 2022

Incidence of nausea and vomiting with cytotoxic chemotherapy: a prospective randomised trial of antiemetics.

9

1 reference

10.1016/0277-5379(91)90311-Z

https://api.crossref.org/works/10.1016/0277-5379(91)90311-Z

6 December 2022

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

10

1 reference

10.1016/0277-5379(91)90311-Z

https://api.crossref.org/works/10.1016/0277-5379(91)90311-Z

6 December 2022

Comparison of metoclopramide and metoclopramide plus dexamethasone for complete protection from cisplatinum-induced emesis

12

1 reference

10.1016/0277-5379(91)90311-Z

https://api.crossref.org/works/10.1016/0277-5379(91)90311-Z

6 December 2022

Double-blind controlled trial of the antiemetic efficacy and toxicity of methylprednisolone (MP), metoclopramide (MTC) and domperidone (DMP) in breast cancer patients treated with i.v. CMF.

15

1 reference

10.1016/0277-5379(91)90311-Z

https://api.crossref.org/works/10.1016/0277-5379(91)90311-Z

6 December 2022

Comparison of antiemetic efficacy of domperidone, metoclopramide, and dexamethasone in patients receiving outpatient chemotherapy regimens

16

1 reference

10.1016/0277-5379(91)90311-Z

https://api.crossref.org/works/10.1016/0277-5379(91)90311-Z

6 December 2022

Dose-ranging evaluation of the serotonin antagonist GR-C507/75 (GR38032F) when used as an antiemetic in patients receiving anticancer chemotherapy

21

1 reference

10.1016/0277-5379(91)90311-Z

https://api.crossref.org/works/10.1016/0277-5379(91)90311-Z

6 December 2022

PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONIST

22

1 reference

10.1016/0277-5379(91)90311-Z

https://api.crossref.org/works/10.1016/0277-5379(91)90311-Z

6 December 2022

A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy

23

1 reference

10.1016/0277-5379(91)90311-Z

https://api.crossref.org/works/10.1016/0277-5379(91)90311-Z

6 December 2022

A comparison of ondansetron with metoclopramide in the prophylaxis of chemotherapy-induced nausea and vomiting: a randomized, double-blind study. International Emesis Study Group.

24

1 reference

10.1016/0277-5379(91)90311-Z

https://api.crossref.org/works/10.1016/0277-5379(91)90311-Z

6 December 2022

Metoclopramide in the reduction of nausea and vomiting associated with combined chemotherapy

26

1 reference

10.1016/0277-5379(91)90311-Z

https://api.crossref.org/works/10.1016/0277-5379(91)90311-Z

6 December 2022

Identifiers

10.1016/0277-5379(91)90311-Z

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40754288&oldid=2136462615"